European Union - English - EMA (European Medicines Agency)

retrophin europe ltd - cholic acid - metabolism, inborn errors - bile and liver therapy - cholic acid fgk is indicated for the treatment of inborn errors of primary bile acid synthesis, in infants from one month of age for continuous lifelong treatment through adulthood, encompassing the following single enzyme defects:sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency;2- (or alpha-) methylacyl-coa racemase (amacr) deficiency;cholesterol 7 alpha-hydroxylase (cyp7a1) deficiency.

European Union - English - EMA (European Medicines Agency)

theravia - cholic acid - digestive system diseases; metabolism, inborn errors - bile acids and derivatives - orphacol is indicated for the treatment of inborn errors in primary bile-acid synthesis due to 3β-hydroxy-Δ5-c27-steroid oxidoreductase deficiency or Δ4-3-oxosteroid-5β-reductase deficiency in infants, children and adolescents aged one month to 18 years and adults.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

laboratoires ctrs - cholic acid - capsule - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

retrophin inc - cholic acid - capsule - 50mg

Israel - English - Ministry of Health

megapharm ltd - cholic acid - hard capsule - cholic acid 250 mg - cholic acid - • cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency, • 2- (or alfa - ) methylacyl-coa racemase (amacr) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• cholesterol 7 alfa - hydroxylase (cyp7a1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-c27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-c27-steroid dehydrogenase/isomerase or 3β-hsd or hsd3β7.

Israel - English - Ministry of Health

megapharm ltd - cholic acid - hard capsule - cholic acid 50 mg - cholic acid - •cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency, • 2- (or alfa - ) methylacyl-coa racemase (amacr) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• cholesterol 7 alfa - hydroxylase (cyp7a1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-c27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-c27-steroid dehydrogenase/isomerase or 3β-hsd or hsd3β7.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

laboratoires ctrs - cholic acid - capsule - 250mg